NDC 60219-2044-01 - dexamethasone
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 60219-2044
- Requested NDC
- 60219-2044-01
- Package NDCs from labels
- 60219-2044-1, 60219-2044-01
- Manufacturer
- Preferred Pharmaceuticals Inc.
- Effective date
- 2026-04-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Dexamethasone Tablets, USP (4 mg and 6 mg) Rx Only | Preferred Pharmaceuticals Inc. | 2026-04-01 | HUMAN PRESCRIPTION DRUG LABEL |
| dexamethasone - Major Pharmaceuticals | Major Pharmaceuticals | 2026-03-26 | HUMAN PRESCRIPTION DRUG LABEL |
| dexamethasone - RedPharm Drug, Inc | RedPharm Drug, Inc | 2024-08-01 | HUMAN PRESCRIPTION DRUG LABEL |
| dexamethasone - Amneal Pharmaceuticals NY LLC | Amneal Pharmaceuticals NY LLC | 2024-02-21 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 60219-2044-1 | dexamethasone | 100 in 1 BOTTLE, PLASTIC | TABLET | 100 | 9 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 60219-2044 | DEXAMETHASONE TABLET [AMNEAL PHARMACEUTICALS NY LLC] | 9 | Current NDC, Legacy NDC, 1 package rows | 20240717_ac71f888-c83a-46a5-921c-1ebdf6cfadc1.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 60219-2044-1 | EA - Each | 60219-2044 | edcd7bcc-8411-4ec8-ae73-27f4b19fa0c8 | 1 | 2021-11-09 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Caldesene Medicated Protecting | CORNSTARCH AND ZINC OXIDE | Insight Pharmaceuticals LLC | ffc92a0f-a7cf-4a46-b2f1-089df2bbb96b | 2026-04-22 | Warnings | O8232NY3SJ |
| Dexamethasone | DEXAMETHASONE | Pangea Pharmaceuticals, LLC | 37607468-0331-44c0-9bb4-5c614c7b69d4 | 2026-04-19 | Warnings, Adverse reactions | 7S5I7G3JQL |
| Ciprofloxacin and dexamethasone | CIPROFLOXACIN AND DEXAMETHASONE | Sentiss Pharmaceuticals LLC | 355fa56f-d7a8-444e-9dec-8ba1fa4ab0d8 | 2026-04-16 | Warnings, Adverse reactions | 7S5I7G3JQL |
| Ciprofloxacin and dexamethasone | CIPROFLOXACIN AND DEXAMETHASONE | Sun Pharmaceutical Industries, Inc. | 641bad60-9b9e-43ea-936e-5c38f27835b2 | 2026-04-02 | Warnings, Adverse reactions | 7S5I7G3JQL |
| dexamethasone | DEXAMETHASONE | Preferred Pharmaceuticals Inc. | 4c619d48-8cf9-4085-8405-c8f066bce19c | 2026-04-01 | Warnings, Adverse reactions | ANDA215106 68788-8293-1 68788-8293-5 68788-8293 197583 0af63cdb-85ed-4dda-86ec-9ac2fa29e989 4c619d48-8cf9-4085-8405-c8f066bce19c 7S5I7G3JQL |
| Dexamethasone | DEXAMETHASONE | Preferred Pharmaceuticals, Inc. | c4d1e578-a1d2-4d5e-8426-6b2c39f0d9bd | 2026-04-01 | Warnings, Adverse reactions | 197582 7S5I7G3JQL |
| Tobramycin and Dexamethasone | TOBRAMYCIN AND DEXAMETHASONE | NuCare Pharmaceuticals,Inc. | c33e84ba-4c0c-f738-e053-2995a90aa20a | 2026-03-27 | Warnings, Adverse reactions | 7S5I7G3JQL |
| dexamethasone | DEXAMETHASONE | Major Pharmaceuticals | 64b46398-9b97-45e8-b1ba-1a202d574448 | 2026-03-26 | Warnings, Adverse reactions | ANDA215106 0904-7267-61 0904-7266-61 0904-7266 0904-7267 197582 197583 1c4b00a6-64d3-47f1-a206-b84aa969fd37 64b46398-9b97-45e8-b1ba-1a202d574448 7S5I7G3JQL |
| Tobramycin and Dexamethasone | TOBRAMYCIN AND DEXAMETHASONE | Sportpharm LLC | 7ed85675-bc46-4dd6-bb8f-7e98c3eb84e2 | 2026-03-20 | Warnings, Adverse reactions | 7S5I7G3JQL |
| Ciprofloxacin and dexamethasone | CIPROFLOXACIN AND DEXAMETHASONE | NuCare Pharmaceutical, Inc. | 4d650d9d-a98a-2dbe-e063-6294a90a0077 | 2026-03-19 | Warnings, Adverse reactions | 7S5I7G3JQL |
| OZURDEX | DEXAMETHASONE | Allergan, Inc. | 4b204f44-6e8a-4d17-803c-268f0b04679f | 2026-03-11 | Warnings, Adverse reactions | 7S5I7G3JQL |
| Tobramycin and Dexamethasone | TOBRAMYCIN AND DEXAMETHASONE | Preferred Pharmaceuticals Inc. | 8a143864-e36b-49bf-91b4-c6cc1a928031 | 2026-02-26 | Warnings, Adverse reactions | 7S5I7G3JQL |
| Ciprofloxacin and Dexamethasone | CIPROFLOXACIN HYDROCHLORIDE AND DEXAMETHASONE | Upsher-Smith Laboratories, LLC | 9c5994d1-01d1-493c-a6ae-94754cd59389 | 2026-02-13 | Warnings, Adverse reactions | 7S5I7G3JQL |
| DEXAMETHASONE | DEXAMETHASONE | NuCare Pharmaceuticals, Inc. | 4a808dd5-35b7-e879-e063-6394a90a0bf7 | 2026-02-10 | Warnings, Adverse reactions | 7S5I7G3JQL |
| Dexamethasone | DEXAMETHASONE | Direct_Rx | 0a0db8e7-8474-3d08-e063-6294a90af3f5 | 2026-02-06 | Warnings, Adverse reactions | 7S5I7G3JQL |
| Dexamethasone | DEXAMETHASONE | Bryant Ranch Prepack | e830be9d-0a8c-4712-93c6-284c208d6f0d | 2026-02-05 | Warnings, Adverse reactions | 197582 7S5I7G3JQL |
| Dexamethasone | DEXAMETHASONE | Bryant Ranch Prepack | b3217057-5945-452c-aa99-ab696fd8b5e7 | 2026-02-04 | Warnings, Adverse reactions | 7S5I7G3JQL |
| Tobramycin and Dexamethasone | TOBRAMYCIN AND DEXAMETHASONE | A-S Medication Solutions | cdd9086d-821f-4ac8-bc49-f1869dffb150 | 2026-01-29 | Warnings, Adverse reactions | 7S5I7G3JQL |
| Neomycin and Polymyxin B Sulfates and Dexamethasone | NEOMYCIN SULFATE, POLYMYXIN B SULFATE, AND DEXAMETHASONE | NuCare Pharmaceuticals,Inc. | c3b6004a-8cfc-d5f8-e053-2a95a90a3efb | 2026-01-21 | Warnings, Adverse reactions | 7S5I7G3JQL |
| Dexamethasone | DEXAMETHASONE | Preferred Pharmaceuticals Inc. | 64577454-d49e-4180-99e6-8461f74b0221 | 2026-01-20 | Warnings, Adverse reactions | 7S5I7G3JQL |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.